PNC FINANCIAL SERVICES GROUP, INC. - HEPION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$44,646
+158.4%
57,534
-0.1%
0.00%
Q4 2022$17,278
-40.4%
57,594
+0.1%
0.00%
Q3 2022$29,000
-12.1%
57,5340.0%0.00%
Q2 2022$33,000
-55.4%
57,5340.0%0.00%
Q1 2022$74,000
+12.1%
57,5340.0%0.00%
Q4 2021$66,000
+10.0%
57,534
+47.4%
0.00%
Q3 2021$60,00039,034
+134500.0%
0.00%
Q3 2019$0290.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 923,230$2,022,0000.82%
Worth Venture Partners, LLC 233,947$512,0000.40%
PERKINS CAPITAL MANAGEMENT INC 150,000$329,0000.22%
GSA CAPITAL PARTNERS LLP 89,067$195,0000.03%
PREMIER ASSET MANAGEMENT LLC 70,000$153,0000.03%
Allen Capital Group, LLC 23,685$52,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$110,0000.01%
Prospera Financial Services Inc 39,300$86,0000.01%
Onex Canada Asset Management Inc. 20,000$44,0000.00%
Schonfeld Strategic Advisors LLC 95,300$208,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders